Novartis CEO Vas Narasimhan: Expect solid growth this year top and bottom line

CNBC’s Angelica Peebles and Novartis CEO Vas Narasimhan join ‘Squawk Box’ to discuss the company’s drug pipeline, managing patent cliffs, drug pricing under Trump, and more.

Source link